Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.200
+0.080 (2.56%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Lisata Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -16.59 | -19.99 | -20.84 | -54.23 | -27.47 | |
| Depreciation & Amortization | 0.15 | 0.17 | 0.19 | 0.07 | 0.06 | |
| Loss (Gain) From Sale of Assets | - | - | 0 | - | - | |
| Asset Writedown & Restructuring Costs | 0.13 | - | - | 30.39 | - | |
| Loss (Gain) From Sale of Investments | -0.08 | -0.46 | -0.96 | 0.79 | 2.51 | |
| Loss (Gain) on Equity Investments | - | 0.13 | - | - | - | |
| Stock-Based Compensation | 1.23 | 1.65 | 2.04 | 2.64 | 2.01 | |
| Provision & Write-off of Bad Debts | 0.5 | - | - | - | - | |
| Change in Accounts Receivable | 0.4 | -0.9 | - | - | - | |
| Change in Accounts Payable | -2.57 | -1 | 0.09 | -0.22 | 1.25 | |
| Change in Other Net Operating Assets | 0.88 | 1.02 | -0.55 | -0.61 | -0.6 | |
| Operating Cash Flow | -15.95 | -19.36 | -20.03 | -21.17 | -22.25 | |
| Capital Expenditures | -0.03 | - | - | -0.29 | -0.06 | |
| Cash Acquisitions | - | - | - | -3.32 | - | |
| Investment in Securities | 15.11 | 13.23 | 10.1 | 32.52 | -54.84 | |
| Investing Cash Flow | 15.09 | 13.23 | 10.1 | 28.91 | -54.9 | |
| Issuance of Common Stock | 0.85 | 0.07 | 0.48 | 0.04 | 85.52 | |
| Repurchase of Common Stock | -0.25 | -0.27 | -0.09 | -0.27 | -0.25 | |
| Financing Cash Flow | 0.6 | -0.21 | 0.39 | -0.22 | 85.28 | |
| Foreign Exchange Rate Adjustments | 0.01 | -0.06 | -0.02 | -0.01 | - | |
| Net Cash Flow | -0.25 | -6.38 | -9.56 | 7.51 | 8.14 | |
| Free Cash Flow | -15.98 | -19.36 | -20.03 | -21.46 | -22.31 | |
| Free Cash Flow Margin | -9398.24% | -1935.60% | - | - | - | |
| Free Cash Flow Per Share | -1.84 | -2.32 | -2.48 | -4.14 | -6.05 | |
| Levered Free Cash Flow | -10.85 | -13.07 | -14.36 | -14.11 | -15.45 | |
| Unlevered Free Cash Flow | -10.85 | -13.07 | -14.36 | -14.11 | -15.45 | |
| Change in Working Capital | -1.29 | -0.87 | -0.46 | -0.83 | 0.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.